Antidepressant Prescribing and Suicide/Self-Harm by Young Australians: Regulatory Warnings, Contradictory Advice, and Long-Term Trends.

Australia US Food and Drug Administration adolescents antidepressants backlash children self-harm suicide

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2020
Historique:
received: 26 11 2019
accepted: 11 05 2020
entrez: 27 6 2020
pubmed: 27 6 2020
medline: 27 6 2020
Statut: epublish

Résumé

In 2004, the US Food and Drug Administration (FDA) controversially issued a black box warning that antidepressants were associated with an increased risk of suicidal thoughts and behaviours in people aged under 18 years. In 2007, the warning was expanded to include young adults aged under 25 years. In 2005, the Australian Therapeutic Goods Administration responded to the FDA warning by requiring Product and Consumer Information leaflets to be updated to reflect the risk. However, there was considerable debate, and at times emotive backlash, in academic journals and the international media. Prominent US and Australian mental health organisations and psychiatrists challenged the FDA warning. They argued that, on balance, antidepressant use was likely to reduce the risk of suicide. Several ecological studies were cited misleadingly as evidence that decreasing antidepressant use increases suicide risk. From 2008 to 2018, Australian per-capita child, adolescent and young adult antidepressant dispensing (0-27 years of age) and suicide (0-24 years) rates have increased approximately 66% and 49%, respectively. In addition, there was a 98% increase in intentional poisonings among 5 to 19 year-olds in New South Wales and Victoria between 2006 and 2016, with substantial overlap between the most commonly dispensed psychotropics and the drugs most commonly used in self-poisoning. These results do not support claims that increased antidepressant use reduces youth suicide risk. They are more consistent with the FDA warning and the hypothesis that antidepressant use increases the risk of suicide and self-harm by young people. Causal relationships cannot be established with certainty until there is a vast improvement in post-marketing surveillance. However, there is clear evidence that more young Australians are taking antidepressants, and more young Australians are killing themselves and self-harming, often by intentionally overdosing on the very substances that are supposed to help them.

Identifiants

pubmed: 32587531
doi: 10.3389/fpsyt.2020.00478
pmc: PMC7299202
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

478

Informations de copyright

Copyright © 2020 Whitely, Raven and Jureidini.

Références

Early Interv Psychiatry. 2013 Feb;7(1):31-43
pubmed: 22672533
BMC Health Serv Res. 2012 Jun 27;12:178
pubmed: 22738436
Am Fam Physician. 2013 Oct 1;88(7):466-7
pubmed: 24134088
BMJ. 2008 Aug 04;337:a695
pubmed: 18678593
Med J Aust. 2010 Aug 2;193(3):133-4
pubmed: 20678036
Am J Epidemiol. 1998 Jan 15;147(2):155-60
pubmed: 9457005
Front Psychiatry. 2020 Feb 13;11:18
pubmed: 32116839
JAMA. 2004 Aug 18;292(7):807-20
pubmed: 15315995
Br J Psychiatry. 2010 Jun;196(6):429-33
pubmed: 20513850
BMJ. 2009 Aug 11;339:b2880
pubmed: 19671933
Aust N Z J Psychiatry. 2014 Oct;48(10):917-31
pubmed: 24927734
PLoS One. 2012;7(9):e45515
pubmed: 23029065
Front Psychiatry. 2019 Oct 11;10:705
pubmed: 31681028
Am J Psychiatry. 2007 Sep;164(9):1356-63
pubmed: 17728420
Am J Psychiatry. 2006 Nov;163(11):1898-904
pubmed: 17074941
BMC Med Res Methodol. 2017 Dec 29;17(1):181
pubmed: 29287585
J Am Acad Child Adolesc Psychiatry. 2003 Apr;42(4):386-405
pubmed: 12649626
Int J Risk Saf Med. 2015;27(2):85-91
pubmed: 26410011
Lancet. 2016 Aug 27;388(10047):881-90
pubmed: 27289172
BMJ Open. 2019 Feb 20;9(2):e026001
pubmed: 30787095
BMJ. 2007 Aug 18;335(7615):329
pubmed: 17703041
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004851
pubmed: 17636776
Am J Psychiatry. 2006 Jan;163(1):41-7
pubmed: 16390887
N Engl J Med. 2007 Jun 7;356(23):2343-6
pubmed: 17485726
BMJ. 2003 May 10;326(7397):1008
pubmed: 12742921

Auteurs

Martin Whitely (M)

John Curtin Institute of Public Policy, Curtin University, Perth, WA, Australia.

Melissa Raven (M)

Critical and Ethical Mental Health Research Group, Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.

Jon Jureidini (J)

Critical and Ethical Mental Health Research Group, Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.

Classifications MeSH